CALCISPRAY

Calcispray Nasal Spray contains an active component as Calcitonin. It is a hormone that plays a role in calcium regulation in the body. The thyroid gland primarily produces it and helps to lower blood calcium levels by inhibiting calcium release from bones and increasing calcium excretion by the kidneys. In medical practice, synthetic versions are used as medications to treat certain conditions.

This medication treats postmenopausal osteoporosis, Paget’s disease (type of bone disease), and hypercalcemia and prevents bone loss in patients suffering from fractures. It makes the bone stronger and prevents further damage. Calcispray Nasal Spray may alleviate bone pain in some cancer patients whose cancer has metastasised to the bones.

This medication should not be used in individuals who have a known hypersensitivity or allergy to calcitonin or any of its components. Allergic reactions may include skin rash, itching, swelling, or difficulty breathing.

This medication is used to lower blood calcium levels, so it should not be administered to patients with already low calcium levels (hypocalcemia). Patients with impaired kidney function may need dosage adjustments, as the kidneys excrete this medication. Close monitoring is essential to prevent any potential accumulation of the Calcispray Nasal Spray. Calcispray Nasal Spray may cause gastrointestinal side effects such as nausea, vomiting, or diarrhoea.